<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-02-05 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment." The purpose of this draft guidance is to foster greater efficiency in drug development in this rare disease with the goal of enhancing clinical trial data quality and supporting the development of treatments for mucopolysaccharidosis type III. Specifically, the draft guidance provides the ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-02220</p>
    <p><strong>Publication Date:</strong> 2020-02-05</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/02/05/2020-02220/mucopolysaccharidosis-type-iii-sanfilippo-syndrome-developing-drugs-for-treatment-draft-guidance-for">https://www.federalregister.gov/documents/2020/02/05/2020-02220/mucopolysaccharidosis-type-iii-sanfilippo-syndrome-developing-drugs-for-treatment-draft-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-02220</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
